Home
Publishers
Categories
Trending
Inbox

Create Account
Sign in

- Nederlands
- Deutsch

Trial tests strategy to augment response to COVID-19 vaccines in transplant recipients

Click here to subscribe to Niaid.nih.gov

Loading...

2 years ago

Html
Text

Having trouble viewing this email? View it as a Web page.

You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).

Trial tests strategy to augment response to COVID-19 vaccines in transplant recipients 01/31/2022 09:00 AM EST
NIH study will reduce immunosuppressive medication before, after extra vaccine dose.

Update Your E-mail Address | Add Subscriptions | Unsubscribe All

If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view ourFrequently Asked Questions page, our Health Information page, or Search our website.

This service is provided to you by the National Institutes of Health.
NIHTurning Discovery Into Health

This email was sent to newsletter@newslettercollector.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) 9000 Rockville Pike Bethesda MD 20892 301-496-4000 / TTY 301-402-9612

Share on

Loading...

Other newsletters from Niaid.nih.gov

CMS Announces Proposed Rule on Medicare Par t D and Medicaid Prescription Drug Programs Niaid.nih.gov
18 minutes ago
Funding news for global health researchers: November 25, 2024 Niaid.nih.gov
an hour ago
How the Current Continuing Resolu tion Impacts You and Your Project Niaid.nih.gov
an hour ago

More newsletters from Niaid.nih.gov

Loading...

Related newsletters

© 2024

Information
Terms and Conditions
Privacy

Home
Publishers
Categories
Trending
Inbox

Create Account
Sign in

© 2024

Information
Terms and Conditions
Privacy

- Nederlands
- Deutsch